These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30051224)

  • 1. Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies.
    Lin S; Zhang C; Ye S
    Int J Clin Pharm; 2018 Oct; 40(5):1030-1036. PubMed ID: 30051224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary experience with tigecycline treatment for severe infection in children.
    Ye S; Zhang C; Lin S
    Eur J Pediatr; 2018 Oct; 177(10):1489-1496. PubMed ID: 30008076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline salvage therapy for critically ill children with multidrug-resistant/extensively drug-resistant infections after surgery.
    Song Y; Hu L; Shu Q; Ye J; Liang J; Chen X; Tan L
    Int J Infect Dis; 2018 Oct; 75():82-88. PubMed ID: 30125690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage tigecycline in high risk febrile neutropenic patients with hematological malignancies: a prospective multicenter study.
    Zhou XP; Ye XJ; Shen JP; Lan JP; Jiang HF; Zhang J; Zhang XJ; Li L; Qian SX; Tong HY
    Leuk Lymphoma; 2018 Nov; 59(11):2679-2685. PubMed ID: 29448851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline therapy in pediatric patients with multidrug resistant bacteremia.
    Ozkaya-Parlakay A; Gulhan B; Kanik-Yuksek S; Guney D; Gonulal D; Demirtas G; Tezer H; Unal S; Senel E
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Dec; 38(10):471-473. PubMed ID: 32081452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Tigecycline to Treat Multidrug-resistant Infections in Pediatrics: An Evidence Synthesis.
    Sharland M; Rodvold KA; Tucker HR; Baillon-Plot N; Tawadrous M; Hickman MA; Raber S; Korth-Bradley JM; Díaz-Ponce H; Wible M
    Pediatr Infect Dis J; 2019 Jul; 38(7):710-715. PubMed ID: 31192975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of tigecycline shows that it may be an option for children with severe infections.
    Zhu ZY; Yang JF; Ni YH; Ye WF; Wang J; Wu ML
    Acta Paediatr; 2016 Oct; 105(10):e480-4. PubMed ID: 27381360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies-a retrospective single-centre analysis of 200 cases.
    Geßner D; Berisha M; Esser T; Schalk E
    Ann Hematol; 2023 Sep; 102(9):2607-2616. PubMed ID: 37186157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals.
    Schwab KS; Hahn-Ast C; Heinz WJ; Germing U; Egerer G; Glasmacher A; Leyendecker C; Marklein G; Nellessen CM; Brossart P; von Lilienfeld-Toal M
    Infection; 2014 Feb; 42(1):97-104. PubMed ID: 23979853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory responses to tigecycline in children.
    Aslan K; Kiliç Ö; Kiral E; Bozan G; Bör Ö; Dinleyici EÇ
    J Clin Pharm Ther; 2022 Oct; 47(10):1585-1590. PubMed ID: 36196509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.
    Heizmann WR; Löschmann PA; Eckmann C; von Eiff C; Bodmann KF; Petrik C
    Infection; 2015 Feb; 43(1):37-43. PubMed ID: 25367409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.
    Eckmann C; Heizmann W; Bodmann KF; von Eiff C; Petrik C; Loeschmann PA
    Surg Infect (Larchmt); 2015 Oct; 16(5):618-25. PubMed ID: 26115414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline-based prolonged salvage therapy in patients presenting with complex bone and joint infection.
    Wach J; Dinh A; Dutronc H; Sipahi OR; Candevir A; Valour F; Zeller V; Lustig S; Laurent F; Chidiac C; Ferry T;
    Med Mal Infect; 2018 Feb; 48(1):53-57. PubMed ID: 29031650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with tigecycline compassionate use in pediatric patients infected with carbapenem resistant Klebsiella pneumoniae].
    Hurtado IC; Trujillo M; Restrepo A; Garcés C; Tamayo C; Mesa JG
    Rev Chilena Infectol; 2012 Jun; 29(3):317-21. PubMed ID: 23096472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an antibiotic stewardship program on tigecycline use in a Tertiary Care Hospital, an intervention study.
    Moghnieh R; Abdallah D; Awad L; Jadayel M; Haddad N; Tamim H; Zaiter A; Awwad DC; Sinno L; El-Hassan S; Lakkis R; Khalil R; Jisr T
    Ann Clin Microbiol Antimicrob; 2020 Aug; 19(1):35. PubMed ID: 32762758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.
    Bassetti M; Eckmann C; Bodmann KF; Dupont H; Heizmann WR; Montravers P; Guirao X; Capparella MR; Simoneau D; Sánchez García M
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii5-14. PubMed ID: 23772047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline salvage therapy for ventriculoperitoneal shunt meningitis due to extensively drug-resistant Acinetobacter baumannii.
    Polat M; Ozkaya-Parlakay A
    Eur J Pediatr; 2019 Jan; 178(1):117-118. PubMed ID: 30353221
    [No Abstract]   [Full Text] [Related]  

  • 20. Tigecycline: a glycylcycline antimicrobial agent.
    Doan TL; Fung HB; Mehta D; Riska PF
    Clin Ther; 2006 Aug; 28(8):1079-1106. PubMed ID: 16982286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.